A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Analysts are positive on these five top "strong buy" dividend stocks for this year. They make sense for growth and income ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Federal science agencies have renewed and increased funding for a world-renowned digital archive of protein structures housed ...

In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds, and that’s definitely the case right now for Georgia and South Carolina.

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...